225 related articles for article (PubMed ID: 22222454)
21. [Bacterial type II topoisomerases as targets for antibacterial drugs].
Pietrusiński M; Staczek P
Postepy Biochem; 2006; 52(3):271-82. PubMed ID: 17201062
[TBL] [Abstract][Full Text] [Related]
22. Antibacterial drug discovery and structure-based design.
Barker JJ
Drug Discov Today; 2006 May; 11(9-10):391-404. PubMed ID: 16635801
[TBL] [Abstract][Full Text] [Related]
23. Bacterial DNA replication enzymes as targets for antibacterial drug discovery.
Sanyal G; Doig P
Expert Opin Drug Discov; 2012 Apr; 7(4):327-39. PubMed ID: 22458504
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, structure and antibacterial activity of novel 1-(5-substituted-3-substituted-4,5-dihydropyrazol-1-yl)ethanone oxime ester derivatives.
Liu XH; Cui P; Song BA; Bhadury PS; Zhu HL; Wang SF
Bioorg Med Chem; 2008 Apr; 16(7):4075-82. PubMed ID: 18262793
[TBL] [Abstract][Full Text] [Related]
25. Isothiazolopyridones: synthesis, structure, and biological activity of a new class of antibacterial agents.
Wiles JA; Hashimoto A; Thanassi JA; Cheng J; Incarvito CD; Deshpande M; Pucci MJ; Bradbury BJ
J Med Chem; 2006 Jan; 49(1):39-42. PubMed ID: 16392790
[TBL] [Abstract][Full Text] [Related]
26. Structure-based design of new DHFR-based antibacterial agents: 7-aryl-2,4-diaminoquinazolines.
Li X; Hilgers M; Cunningham M; Chen Z; Trzoss M; Zhang J; Kohnen L; Lam T; Creighton C; G C K; Nelson K; Kwan B; Stidham M; Brown-Driver V; Shaw KJ; Finn J
Bioorg Med Chem Lett; 2011 Sep; 21(18):5171-6. PubMed ID: 21831637
[TBL] [Abstract][Full Text] [Related]
27. Pyridine-3-carboxamide-6-yl-ureas as novel inhibitors of bacterial DNA gyrase: structure based design, synthesis, SAR and antimicrobial activity.
Yule IA; Czaplewski LG; Pommier S; Davies DT; Narramore SK; Fishwick CW
Eur J Med Chem; 2014 Oct; 86():31-8. PubMed ID: 25137573
[TBL] [Abstract][Full Text] [Related]
28. Emerging bacterial enzyme targets.
Su Z; Honek JF
Curr Opin Investig Drugs; 2007 Feb; 8(2):140-9. PubMed ID: 17328230
[TBL] [Abstract][Full Text] [Related]
29. Potent DNA gyrase inhibitors; novel 5-vinylpyrazole analogues with Gram-positive antibacterial activity.
Tanitame A; Oyamada Y; Ofuji K; Suzuki K; Ito H; Kawasaki M; Wachi M; Yamagishi J
Bioorg Med Chem Lett; 2004 Jun; 14(11):2863-6. PubMed ID: 15125948
[TBL] [Abstract][Full Text] [Related]
30. Kibdelomycin A, a congener of kibdelomycin, derivatives and their antibacterial activities.
Singh SB; Goetz MA; Smith SK; Zink DL; Polishook J; Onishi R; Salowe S; Wiltsie J; Allocco J; Sigmund J; Dorso K; de la Cruz M; Martín J; Vicente F; Genilloud O; Donald RG; Phillips JW
Bioorg Med Chem Lett; 2012 Dec; 22(23):7127-30. PubMed ID: 23084277
[TBL] [Abstract][Full Text] [Related]
31. Novel pyrazole derivatives as potent inhibitors of type II topoisomerases. Part 1: synthesis and preliminary SAR analysis.
Gomez L; Hack MD; Wu J; Wiener JJ; Venkatesan H; Santillán A; Pippel DJ; Mani N; Morrow BJ; Motley ST; Shaw KJ; Wolin R; Grice CA; Jones TK
Bioorg Med Chem Lett; 2007 May; 17(10):2723-7. PubMed ID: 17368897
[TBL] [Abstract][Full Text] [Related]
32. Discovery and optimization of antibacterial AccC inhibitors.
Cheng CC; Shipps GW; Yang Z; Sun B; Kawahata N; Soucy KA; Soriano A; Orth P; Xiao L; Mann P; Black T
Bioorg Med Chem Lett; 2009 Dec; 19(23):6507-14. PubMed ID: 19875284
[TBL] [Abstract][Full Text] [Related]
33. Discovery of novel benzene 1,3-dicarboxylic acid inhibitors of bacterial MurD and MurE ligases by structure-based virtual screening approach.
Perdih A; Kovac A; Wolber G; Blanot D; Gobec S; Solmajer T
Bioorg Med Chem Lett; 2009 May; 19(10):2668-73. PubMed ID: 19369074
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and antibacterial activity of a novel series of DNA gyrase inhibitors: 5-[(E)-2-arylvinyl]pyrazoles.
Tanitame A; Oyamada Y; Ofuji K; Terauchi H; Kawasaki M; Wachi M; Yamagishi J
Bioorg Med Chem Lett; 2005 Oct; 15(19):4299-303. PubMed ID: 16087337
[TBL] [Abstract][Full Text] [Related]
35. Discovery of novel bacterial RNA polymerase inhibitors: pharmacophore-based virtual screening and hit optimization.
Hinsberger S; Hüsecken K; Groh M; Negri M; Haupenthal J; Hartmann RW
J Med Chem; 2013 Nov; 56(21):8332-8. PubMed ID: 24112046
[TBL] [Abstract][Full Text] [Related]
36. Discovery of (3S)-amino-(4R)-ethylpiperidinyl quinolones as potent antibacterial agents with a broad spectrum of activity and activity against resistant pathogens.
Hu XE; Kim NK; Gray JL; Almstead JI; Seibel WL; Ledoussal B
J Med Chem; 2003 Aug; 46(17):3655-61. PubMed ID: 12904069
[TBL] [Abstract][Full Text] [Related]
37. Pharmacophore identification and virtual screening for methionyl-tRNA synthetase inhibitors.
Bharatham N; Bharatham K; Lee KW
J Mol Graph Model; 2007 Mar; 25(6):813-23. PubMed ID: 16996282
[TBL] [Abstract][Full Text] [Related]
38. Tetrahydroindazole inhibitors of bacterial type II topoisomerases. Part 2: SAR development and potency against multidrug-resistant strains.
Wiener JJ; Gomez L; Venkatesan H; Santillán A; Allison BD; Schwarz KL; Shinde S; Tang L; Hack MD; Morrow BJ; Motley ST; Goldschmidt RM; Shaw KJ; Jones TK; Grice CA
Bioorg Med Chem Lett; 2007 May; 17(10):2718-22. PubMed ID: 17382544
[TBL] [Abstract][Full Text] [Related]
39. A 4.2 kDa synthetic peptide as a potential probe to evaluate the antibacterial activity of coumarin drugs.
Scatigno AC; Garrido SS; Marchetto R
J Pept Sci; 2004 Sep; 10(9):566-77. PubMed ID: 15473264
[TBL] [Abstract][Full Text] [Related]
40. Discovery of antibacterial biotin carboxylase inhibitors by virtual screening and fragment-based approaches.
Mochalkin I; Miller JR; Narasimhan L; Thanabal V; Erdman P; Cox PB; Prasad JV; Lightle S; Huband MD; Stover CK
ACS Chem Biol; 2009 Jun; 4(6):473-83. PubMed ID: 19413326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
